State and Federal Developments

Resources that reflect developments regarding federal and state responses to the opioid epidemic.

  • Pharmacist Scope of Practice: Prescribing Medications for Opioid Use Disorder (State-Specific Map) (APhA)
  • Overview of Pharmacists’ Prescriptive Authority of Controlled Substances
  • Pharmacist Controlled Substance Authority by State
  • X-Waiver Requirement Removal FAQ (SAMHSA)
  • Opioid Analgesic REMS 
  • National Prescription Drug Take Back Day event (DEA)
  • National Prescription Drug Take Back Day (DEA)
  • Reducing Opioid Misuse Letter to Providers (CMS) 
  • 2019 Medicare Part D Opioid Policies: Information for Pharmacies (Tip Sheet) (a webinar is also available) (CMS)   
  • Opioid Prescribing by Specialty and Volume in the U.S. (CDC) 
  • Surgeon General's Spotlight on Opioids: Facing Addiction in America
  • Help, Resources and Information, National Opioid Crisis (HHS) 
  • HEAL Initiative Research Plan (NIH)
  • Surgeon General's Advisory on Naloxone and Opioid Overdose (April 2018)
  • DEA 360 Strategy
  • Opioids (Agency for Health Research and Quality) 
  • White House: The Opioid Crisis
  • Naloxone Access in Community Pharmacies (National Alliance of State Pharmacy Associations)
  • The Surgeon General's Report on Alcohol, Drugs, and Health - Facing Addiction in America (November 2016)
  • National Pain Strategy (HHS)
  • Preventing the Consequences of Opioid Overdose: Understanding Naloxone Access Laws (SAMHSA)
  • National and state treatment need and capacity for opioid antagonist medication-assisted treatment
  • Fact Sheet – FDA Opioids Action Plan
  • Prescription Drug Time and Dosage Limit Laws (CDC)
  • The Role of a Prescription Drug Monitoring Program in Reducing Prescription Drug Diversion, Misuse, and Abuse (CMS)
  • State Laws on Prescription Drug Abuse and Misuse (CDC)